WO2005040208A3 - Peptides derived from heat shock proteins binding toll-like receptors 2 and 4 and their use - Google Patents
Peptides derived from heat shock proteins binding toll-like receptors 2 and 4 and their use Download PDFInfo
- Publication number
- WO2005040208A3 WO2005040208A3 PCT/US2004/034915 US2004034915W WO2005040208A3 WO 2005040208 A3 WO2005040208 A3 WO 2005040208A3 US 2004034915 W US2004034915 W US 2004034915W WO 2005040208 A3 WO2005040208 A3 WO 2005040208A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- receptors
- heat shock
- peptides derived
- shock proteins
- proteins binding
- Prior art date
Links
- 102000002689 Toll-like receptor Human genes 0.000 title abstract 3
- 108020000411 Toll-like receptor Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000002812 Heat-Shock Proteins Human genes 0.000 title 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000816 peptidomimetic Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Toll-like receptor-binding molecules (including peptides and peptidomimetics) are described. Also described are compositions that contain such TLR-binding molecules and methods of using such molecules to modulate immune responses, for example, to treat or prevent certain immune-mediated diseases.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51323103P | 2003-10-21 | 2003-10-21 | |
US60/513,231 | 2003-10-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005040208A2 WO2005040208A2 (en) | 2005-05-06 |
WO2005040208A3 true WO2005040208A3 (en) | 2005-10-20 |
Family
ID=34520082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/034915 WO2005040208A2 (en) | 2003-10-21 | 2004-10-21 | Peptides derived from heat shock proteins binding toll-like receptors 2 and 4 and their use |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005040208A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1881080A1 (en) | 2006-07-18 | 2008-01-23 | Institut Gustave Roussy | Toll like receptor 4 dysfunction and the biological applications thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001043691A2 (en) * | 1999-12-15 | 2001-06-21 | Peptor Ltd. | Fragments and antagonists of heat shock protein 60 |
WO2002085933A1 (en) * | 2001-04-20 | 2002-10-31 | The Institute For Systems Biology | Toll-like receptor 5 ligands and methods of use |
WO2003070761A1 (en) * | 2002-02-19 | 2003-08-28 | Yeda Research And Development Co. Ltd. | Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation |
-
2004
- 2004-10-21 WO PCT/US2004/034915 patent/WO2005040208A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001043691A2 (en) * | 1999-12-15 | 2001-06-21 | Peptor Ltd. | Fragments and antagonists of heat shock protein 60 |
WO2002085933A1 (en) * | 2001-04-20 | 2002-10-31 | The Institute For Systems Biology | Toll-like receptor 5 ligands and methods of use |
WO2003070761A1 (en) * | 2002-02-19 | 2003-08-28 | Yeda Research And Development Co. Ltd. | Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation |
Non-Patent Citations (4)
Title |
---|
ASEA A ET AL: "Novel signal transduction pathway utilized by extracellular HSP70. Role of toll-like receptor (TLR) 2 and TLR4", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 277, no. 17, 26 April 2002 (2002-04-26), pages 15028 - 15034, XP002971859, ISSN: 0021-9258 * |
VABULAS R M ET AL: "Endocytosed HSP60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 276, no. 33, 17 August 2001 (2001-08-17), pages 31332 - 31339, XP002242849, ISSN: 0021-9258 * |
VAN EDEN W ET AL: "Balancing the immune system: Th1 and Th2", ANNALS OF THE RHEUMATIC DISEASES, vol. 61, no. Supplement 2, November 2002 (2002-11-01), pages ii25 - ii28, XP009051927, ISSN: 0003-4967 * |
VAN EDEN W ET AL: "Immunopotentiating heat shock proteins: negotiators between innate danger and control of autoimmunity", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 21, no. 9-10, 14 February 2003 (2003-02-14), pages 897 - 901, XP004402615, ISSN: 0264-410X * |
Also Published As
Publication number | Publication date |
---|---|
WO2005040208A2 (en) | 2005-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY163480A (en) | Sclerostin binding agents | |
TW200626173A (en) | IL-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses | |
BRPI0513135A (en) | polynucleotide libraries, method of producing them, method of identifying a polynucleotide, binding region, suitable medium for use in an electronic device and device | |
HK1158696A1 (en) | Antagonistic selective binding agents of osteoprotegerin binding protein | |
WO2005016962A3 (en) | Compositions and methods for the treatment of immune related diseases | |
RS20050934A (en) | Antibodies specific for sclerostin and methods fo r increasing bone mineralization | |
WO2004020595A8 (en) | Novel human polypeptides encoded by polynucleotides | |
DE60141773D1 (en) | GREAT SIMILAR RECEPTOR 5-LIGANDS AND USE PROCESS | |
AU6113396A (en) | Novel high affinity human antibodies to tumor antigens | |
AU2002305450A1 (en) | Proteomimetic compounds and methods | |
DE60028970D1 (en) | AT HER2 BINDING PEPTIDE COMPOUNDS | |
WO2005056600A3 (en) | Monoclonal antibodies that bind or neutralize dengue virus | |
WO2003011895A3 (en) | Compositions and methods for modulation of immune responses | |
PL378566A1 (en) | Ligands for tgf-beta binding proteins and uses thereof | |
EP1978994A4 (en) | Bmp-7 variant compositions, methods and uses | |
TW200508246A (en) | Anti-dengue virus antibodies, compositions, methods and uses | |
WO1996031603A3 (en) | Methods and compositions for regulating fadd | |
MX2022016322A (en) | High affinity antibodies targeting tau phosphorylated at serine 413. | |
WO2005040208A3 (en) | Peptides derived from heat shock proteins binding toll-like receptors 2 and 4 and their use | |
WO2003057821A3 (en) | Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses | |
WO2004090103A3 (en) | Identification of novel nogo-receptors and methods related thereto | |
WO2004089302A3 (en) | Posh polypeptides, complexes and related methods | |
WO2002077648A3 (en) | Pathogenic and commensal vaccine antigens | |
WO2004007536A3 (en) | Interactions of the epstein-barr virus protein ebna1, and uses thereof | |
EA200500624A1 (en) | PROMOTER FOR IL-18BP, ITS PREPARATION AND APPLICATION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |